Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29K Hold
899
﹤0.01% 1824
2026
Q1
$32K Hold
899
﹤0.01% 1780
2025
Q4
$36K Hold
899
﹤0.01% 1701
2025
Q3
$42K Hold
899
﹤0.01% 1685
2025
Q2
$47K Sell
899
-539
-37% -$29.6K ﹤0.01% 1624
2025
Q1
$87K Hold
1,438
﹤0.01% 1559
2024
Q4
$98K Buy
1,438
+406
+39% +$28.3K ﹤0.01% 1563
2024
Q3
$74K Hold
1,032
﹤0.01% 1484
2024
Q2
$72K Buy
1,032
+305
+42% +$22.2K ﹤0.01% 1387
2024
Q1
$58K Hold
727
﹤0.01% 1459
2023
Q4
$80K Hold
727
﹤0.01% 1198
2023
Q3
$73K Sell
727
-1,586
-69% -$182K ﹤0.01% 1156
2023
Q2
$314K Sell
2,313
-190
-8% -$23.2K ﹤0.01% 821
2023
Q1
$260K Sell
2,503
-223
-8% -$21.6K ﹤0.01% 901
2022
Q4
$242K Hold
2,726
﹤0.01% 918
2022
Q3
$219K Hold
2,726
﹤0.01% 936
2022
Q2
$261K Sell
2,726
-1,417
-34% -$170K ﹤0.01% 912
2022
Q1
$615K Hold
4,143
﹤0.01% 773
2021
Q4
$587K Hold
4,143
﹤0.01% 828
2021
Q3
$542K Hold
4,143
﹤0.01% 846
2021
Q2
$569K Hold
4,143
﹤0.01% 850
2021
Q1
$541K Hold
4,143
﹤0.01% 852
2020
Q4
$464K Hold
4,143
﹤0.01% 865
2020
Q3
$326K Sell
4,143
-694
-14% -$56.6K ﹤0.01% 875
2020
Q2
$348K Hold
4,837
﹤0.01% 891
2020
Q1
$277K Sell
4,837
-14,075
-74% -$1.3M ﹤0.01% 965
2019
Q4
$2.12M Buy
18,912
+2,396
+15% +$255K 0.01% 673
2019
Q3
$1.59M Buy
16,516
+13,987
+553% +$1.31M 0.01% 717
2019
Q2
$216K Buy
+2,529
New +$208K ﹤0.01% 1217

Other funds holding CNMD

KBC Group's CNMD Position: Q2 2026 in Review

KBC Group held its CONMED (CNMD) position steady in Q2 2026 at 899 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #1824.

KBC Group first reported a position in CNMD in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.12M in Q4 2019. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • KBC Group held 899 shares of CONMED worth $29K as of Q2 2026.
  • KBC Group left its CONMED share count unchanged in Q2 2026.
  • CONMED made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1824 holding.
  • KBC Group first reported a position in CONMED in Q2 2019 and has held it in 29 quarters since.
  • KBC Group's CONMED position peaked at $2.12M in Q4 2019.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.